Skip to main navigation
Skip to search
Skip to main content
Illinois Experts Home
LOGIN & Help
Home
Profiles
Research units
Research & Scholarship
Datasets
Honors
Press/Media
Activities
Search by expertise, name or affiliation
Biomaterial-Based In Situ Cancer Vaccines
Yang Bo,
Hua Wang
Materials Science and Engineering
Bioengineering
Materials Research Lab
Biomedical and Translational Sciences
Beckman Institute for Advanced Science and Technology
Carl R. Woese Institute for Genomic Biology
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Biomaterial-Based In Situ Cancer Vaccines'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antigen Screening
20%
Antigen-presenting Cells
20%
Antigen-specific
20%
Artificial Materials
20%
Biomaterials
100%
Cancer Immunotherapy
40%
Cancer Treatment
20%
Cancer Vaccine
20%
Cellular Response
20%
Cytotoxic T Cell Response
20%
Design Criteria
20%
Epitope Prediction
20%
FDA-approved Drugs
20%
Humoral Response
20%
Immune Cells
20%
In Situ
20%
In Situ Vaccine
100%
Living Materials
20%
Mutation Analysis
20%
Peptide Antigen
20%
Peptide Synthesis
20%
RNA Extraction
20%
Safety Profile
20%
Solid Tumors
20%
Synergize
20%
T Cell Priming
20%
Therapeutic Efficacy
20%
Therapeutic Vaccine
20%
Troubleshooting
20%
Tumor
20%
Tumor Antigen
40%
Tumor Cell Isolation
20%
Medicine and Dentistry
Adjuvant
14%
Antigen
14%
Antigen Presenting Cell
14%
Antigen Specificity
14%
Biocompatible Material
100%
Cancer Immunotherapy
28%
Cancer Therapy
14%
Cancer Vaccine
100%
Combination Therapy
14%
Cytotoxic T-Cell
14%
DNA RNA Hybridization
14%
Epitope
14%
Immunocompetent Cell
14%
Neoplasm
14%
Peptide Synthesis
14%
Solid Malignant Neoplasm
14%
T Cell
14%
Tumor Antigen
28%
Tumor Cell
14%
Pharmacology, Toxicology and Pharmaceutical Science
Adjuvant
14%
Antigen
14%
Biomaterial
100%
Cancer Vaccine
100%
Combination Therapy
14%
Epitope
14%
Immunotherapy
28%
Malignant Neoplasm
42%
Neoplasm
28%
Solid Malignant Neoplasm
14%
Tumor Antigen
28%
Immunology and Microbiology
Adjuvant
14%
Antigen
14%
Antigen Specificity
14%
Antigen-Presenting Cell
14%
Cancer Immunotherapy
28%
Cancer Vaccine
100%
Cell Isolation
14%
Cytotoxic T Cell
14%
DNA RNA Hybridization
14%
Epitope
14%
Immunocompetent Cell
14%
Peptide Synthesis
14%
RNA Extraction
14%
T Cell
14%
Tumor Antigen
28%
Tumor Cell
14%
Material Science
Biomaterial
100%
Epitope
20%
T-Cells
40%
Tumor
100%